Quarterly report pursuant to Section 13 or 15(d)

Inventories

v3.19.1
Inventories
3 Months Ended
Mar. 31, 2019
Inventories  
Inventories

4.Inventories

 

Inventories are comprised of unprocessed tissue, work-in-process, Avance® Nerve Graft, AxoGuard® Nerve Connector, AxoGuard Nerve Protector, Avive® Soft Tissue Membrane, AcroVal Neurosensory and Motor Testing System, AxoTouch® Two-Point Discriminator and supplies and are valued at the lower of cost (first-in, first-out) or net realizable value and consist of the following:

 

 

 

 

 

 

 

 

 

 

    

March 31,

    

December 31,

    

 

 

2019

 

2018

 

 

 

 

 

 

 

Finished goods

 

$

10,001

 

$

9,194

 

Work in process

 

 

387

 

 

454

 

Raw materials

 

 

2,732

 

 

2,334

 

Inventories

 

$

13,120

 

$

11,982

 

 

For the three months ended March 31, 2019 and 2018, the Company had inventory write-downs of $444 and $354 respectively.